Women’s Health Market 2022 | Industry Demand, Fastest Growth, Opportunities Analysis and Forecast To 2028

The global women’s health market size is expected to reach USD 54.6 billion by 2026, according to a new report by Radiant Insights, Inc., expanding at a CAGR of 4.2% over the forecast period.

Government and various private organizations are focused on women health across the globe, which is likely to drive the market in the coming years.

This includes anemia screening on a routine basis, folic acid supplements for women who may become pregnant, hepatitis B screening, breast cancer screening, contraception, and many others.

Healthy People 2020 was established by the Department of Health and Human Services to improve the health of all Americans in 10 years.

For instance, in September 2016, Ministry of Health, Australia, announced funding of AUD 5.6 million (around USD 3.8 million) until 2019 to Jean Hailes, a women’s health organization to help expand its education and outreach.

According to the International Osteoporosis Foundation (IOF), the worldwide prevalence of osteoporosis among women was over 200.0 million in 1990, which is anticipated to reach 680.0 million in 2050.

A new research study from “Data Bridge Market Research”  with title Women’s Health Market Insights 2019, Global  Analysis and Forecast to 2026 provides an in-depth assessment of the Women’s Health including key market trends, upcoming technologies, industry drivers, challenges, regulatory policies, key players company profiles and strategies.

Key players profiled in this report are: Eli Lilly and Company; Novartis AG; Pfizer Inc.; Merck & Co., Inc.; Novo Nordisk A/S; Amgen Inc.; Lupin Pharmaceuticals, Inc.; AstraZeneca; F. Hoffmann-La Roche Ltd; Sanofi; Johnson & Johnson Services, Inc.; GlaxoSmithKline plc; Bayer AG; Theramex; Agile Therapeutics; Blairex Laboratories, Inc.; Bristol-Myers Squibb Company; Ferring B.V.; Abbott; Enteris BioPharma; Evestra, Inc.; Gedeon Richter; HRA Pharma; JDS Therapeutics, LLC; Neurocrine Biosciences, Inc.; Noven Pharmaceuticals, Inc.; Radius HealthGlobal women’s health market is expected to register a steady CAGR of 4.96% in the forecast period of 2019-2026.

The report contains data from the base year of 2018 and the historic year of 2017.A sample of this report is available upon request @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-womens-health-marketSegmentation: Global Women’s Health MarketGlobal Women’s Health Market By Product Type (Devices, Drugs, Pharmaceutical Pipeline)Treatment Type (Hormonal Treatment, Non-Hormonal Treatment, Surgeries)Diagnosis (Bone Densitometry, Diagnostic Imaging Tests, Biopsies, Ovulation Testing, Others)Disease Indication (Cancer, Reproductive Health, Hypothyroidism, Post-Menopausal Syndrome, Urological Disorders, Others)End-Users (Hospitals & Clinics, Gynecology Centers, Research Institutes, Others)Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends & Forecast to 2026Key Developments in the Market:In June 2019, AbbVie Inc. announced that they had agreed with ALLERGAN to acquire the assets available with ALLERGAN for approximately USD 63 billion.

This acquisition is a strategic step for the organizations as the combined capabilities will provide vast areas of applications for the pharmaceuticals organizations as well as driving the innovations in the applicable market.

This acquisition will also provide cash injection into the operations which will provide more areas for revenue generation.In February 2018, CVC VI announced that they had formulated a new company known as Theramex that will deal with providing products, therapeutics to the women population for treatment of contraceptives, fertility, menopause and osteoporosis.

The company will be situated in London, England.

Currently, the market is mainly driven by growing awareness about various health-related disorders, rising incidence of chronic and lifestyle disorders, and the high prevalence of infectious diseases such as HIV and hepatitis in women across the globe.

[270 Pages Report] The women’s health diagnostics market is projected to reach USD 36.6 billion by 2025 from USD 25.0 billion in 2020, at a CAGR of 7.9% during the forecast period.The increasing adoption of POC diagnostic testing and the growth in the number of diagnostic and imaging centers are also expected to support the growth of this market during the forecast period.

However, the high cost of diagnostic devices, tests, and procedures; shortage of skilled laboratory technicians; and insufficient reimbursements for diagnostic tests are expected to restrain this market’s growth to a certain extent.Market DynamicsHigh prevalence of infectious diseases in womenRising incidence of chronic and lifestyle-related disorders in womenIncreasing awareness about fertility testing in women and initiatives by government and health organizationsIncreased adoption of POC and rapid diagnostic testsGrowth in the number of private diagnostic and imaging centersPublic-private partnerships are expected to enhance infrastructure in diagnostic imaging centersBased on application, the women’s health diagnostics market is divided into nine segments—osteoporosis testing, OVC testing, cervical cancer testing, breast cancer testing, pregnancy & fertility testing, prenatal genetic screening & carrier testing, infectious disease testing, STD testing, and ultrasound tests.

The large share of this segment can be attributed to the increasing incidence of breast cancer and rising awareness about advanced breast cancer diagnostic techniques, such as ABUSDownload PDF Brochure@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=128928901COVID-19 Impact on Global Women’s Health Diagnostics MarketSince the beginning of 2020, more and more countries across the globe shut down their borders and limited transportation and travel to contain the coronavirus (COVID-19) outbreak, thus, creating impediments for international trade and transportation.

This had disrupted the supply chains for the women’s health diagnostics market, temporarily leading to fall in demand due to uncertainty in the global economy and capital markets.

Additionally, we are estimating that the major share of the medical devices industry that includes imaging devices, and surgical products among others, which contribute 60-75% of the overall medical devices market will have a stagnant or deep fall in the growth rate in 2020 and couple of quartered from 2021.

In this day and time, important and focus on women and their health has increased significantly.

Governments of various countries are also making substantial efforts in improving and providing better health facilities to women.

Moreover, increasing different types of diseases among women cancer of different parts such as breast, ovaries, and cervical and other disease including UTI, post-menopausal syndrome, hypothyroidism, contraceptive, and osteoporosis has highlighted the need for better and advanced healthcare facilities for women.Request Brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=214 With growing need for better and improved healthcare facilities for women, Transparency Market Research has published a report on the global women’s health market.

The market growing at a healthy rate and with increased focus on providing better health care facilities to the women, opportunities for the stakeholders in this market are estimated to be high and lucrative.Increasing Initiatives Taken by Players in Getting New FDA Approval for New Indication to Benefit Women’s Health MarketWitnessing high growth opportunities in the global women’s health market, players in this market are making constant efforts to increase their revenue share by increasing their presence in different regions.

Leading players are engaged in establishing relationship with companies already existing in specific region through investing in mergers and acquisition, collaboration, partnership, and expansion.

For example, Prolia is given  to women during postmenopausal as women are vulnerable to bone fractures because of osteoporosis.

The Global Women’s Health Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026 gives an evaluation of the market developments based on historical studies and comprehensive research respectively.

The market segments are also provided with an in-depth outlook of the competitive landscape and a listing of the profiled key players.DriversRising occurrences of chronic and lifestyle-related disorders in womenFavorable government policiesRestraintsHigh cost of diagnostic proceduresThe comprehensive value chain analysis of the market will assist in attaining better product differentiation, along with detailed understanding of the core competency of each activity involved.

The market attractiveness analysis provided in the report aptly measures the potential value of the market providing business strategists with the latest growth opportunities.The report classifies the market into different segments based on application.

These segments are studied in detail incorporating the market estimates and forecasts at regional and country level.

The segment analysis is useful in understanding the growth areas and probable opportunities of the market.Browse the complete Global Women’s Health Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026 @ https://www.decisiondatabases.com/ip/21027-womens-health-market-reportThe report also covers the complete competitive landscape of the global Women’s Health market with company profiles of key players such as:Agile TherapeuticsAllergan, Inc.Amgen, Inc.Apothecus Pharmaceutical CorporationAstraZenecaBayer AGBlairex Laboratories, Inc.Bristol-Myers Squibb CompanyFerring B.V.Merck & Co., Inc.Pfizer, Inc.Teva Pharmaceutical Industries Ltd.A detailed description of each has been included, with information in terms of H.Q, future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other latest industrial developments.SEGMENTATIONS IN THE REPORT:By Applications:Postmenopausal OsteoporosisInfertilityEndometriosisContraceptivesMenopausePolycystic Ovary Syndrome (PCOS)By Geography:North America (NA) – US, Canada & Rest of North AmericaEurope (EU) – UK, Germany, France & Rest of EuropeAsia Pacific (APAC) – China, Japan, India & Rest of APACLatin America (LA) – Brazil & Rest of Latin AmericaMiddle East & Africa (MEA) – Middle East and AfricaDownload Free Sample Report of Global Women’s Health Market @ https://www.decisiondatabases.com/contact/download-sample-21027The Global Women’s Health Market has been exhibited in detail in the following chapters -Chapter 1 Women’s Health Market PrefaceChapter 2 Executive SummaryChapter 3 Women’s Health Industry AnalysisChapter 4 Women’s Health Market Value Chain AnalysisChapter 5 Women’s Health Market Analysis By ApplicationsChapter 6 Women’s Health Market Analysis By GeographyChapter 7 Competitive Landscape Of Women’s Health CompaniesChapter 8 Company Profiles Of Women’s Health IndustryPurchase the complete Global Women’s Health Market Research Report @ https://www.decisiondatabases.com/contact/buy-now-21027Other Reports by DecisionDatabases.com:Global Digital Health Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026Global Health Ingredients Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026Global M-Health Applications Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026About-Us:DecisionDatabases.com is a global business research reports provider, enriching decision makers and strategists with qualitative statistics.

DecisionDatabases.com is proficient in providing syndicated research report, customized research reports, company profiles and industry databases across multiple domains.Our expert research analysts have been trained to map client’s research requirements to the correct research resource leading to a distinctive edge over its competitors.

Currently, the market is mainly driven by growing awareness about various health-related disorders, rising incidence of chronic and lifestyle disorders, and the high prevalence of infectious diseases such as HIV and hepatitis in women across the globe.

However, the high cost of diagnostic devices, tests, and procedures; shortage of skilled laboratory technicians; and insufficient reimbursements for diagnostic tests are expected to restrain this market’s growth to a certain extent.Market DynamicsHigh prevalence of infectious diseases in womenRising incidence of chronic and lifestyle-related disorders in womenIncreasing awareness about fertility testing in women and initiatives by government and health organizationsIncreased adoption of POC and rapid diagnostic testsGrowth in the number of private diagnostic and imaging centersPublic-private partnerships are expected to enhance infrastructure in diagnostic imaging centersBased on application, the women’s health diagnostics market is divided into nine segments—osteoporosis testing, OVC testing, cervical cancer testing, breast cancer testing, pregnancy & fertility testing, prenatal genetic screening & carrier testing, infectious disease testing, STD testing, and ultrasound tests.

The large share of this segment can be attributed to the increasing incidence of breast cancer and rising awareness about advanced breast cancer diagnostic techniques, such as ABUSGet a sample PDF copy of the Report @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=128928901COVID-19 Impact on Global Women’s Health Diagnostics MarketSince the beginning of 2020, more and more countries across the globe shut down their borders and limited transportation and travel to contain the coronavirus (COVID-19) outbreak, thus, creating impediments for international trade and transportation.

This had disrupted the supply chains for the women’s health diagnostics market, temporarily leading to fall in demand due to uncertainty in the global economy and capital markets.

Additionally, we are estimating that the major share of the medical devices industry that includes imaging devices, and surgical products among others, which contribute 60-75% of the overall medical devices market will have a stagnant or deep fall in the growth rate in 2020 and couple of quartered from 2021.

A new, USD 5-7 billion market opportunity (by 2021) is opening up in the medical devices industry that includes critical care medical devices.In 2019, North America accounted for the largest share of the women’s health diagnostics market, followed by Europe, the Asia Pacific, Latin America, and the Middle East & Africa.

19 February 2020 - The global Women’s Health Market size was valued at USD 36.5 billion in 2016 and is expected to reach USD 51.3 billion by 2025, with a CAGR of 3.9%.

The general practice management of women’s health involves a general patient-centered approach toward the physical, mental, and emotional health of women, their families, and their relationships.

Women’s health needs to be understood in the perspective of their psychological and cultural environment.In 1900, a woman’s lifespan was about 50 years but now in the new millennium, average life expectancy for American women is 82 years of age, and it is continuing to rise.

Gynecology is the primary branch of medical science concerned with women’s health issues.

The National Institutes of Health (NIH) established Women’s Health Initiative (WHI) in 1991 to address the most common causes of death, disability, and impaired quality of life in postmenopausal women.

The Agency of Healthcare Research and Quality (AHRQ) supports research on all aspects of healthcare provided to women.Request a Sample Copy of This Report @ https://www.millioninsights.com/industry-reports/womens-health-marketWith many countries pitching for improving the healthcare facilities for women, the market for women’s health will have a positive viewpoint in the years to come.